jRCTs041240164招募中不适用
A single-center, open-label study to evaluate the safty of [68Ga] PSMA-11 PET CT in the diagnosis of prostate cancer
未提供0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 主要终点
- Adverse events after administration of [68Ga]PSMA-11
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Diagnostic Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 85age old under（—）
- 性别
- All
入选标准
- •Patients who have been fully informed of the study and have given their voluntary written consent based on their full understanding.
- •Patients aged 20 to 85 years at the time of consent
- •Patients diagnosed with high-risk localized prostate cancer
- •Patients with PSA recurrence after curative treatment for localized prostate cancer
- •Patients diagnosed with non-metastatic castration-resistant prostate cancer
- •Patients diagnosed with metastatic castration-resistant prostate cance
排除标准
- •Patients who have difficulty maintaining a supine position for the duration of the examination (approximately 20 minutes).
- •Patients who are otherwise deemed inappropriate by the principal investigator or co-investigator.
结局指标
主要结局
Adverse events after administration of [68Ga]PSMA-11
Including fatigue, nausea, constipation, and vomiting
次要结局
未报告次要终点
研究者
相似试验
进行中（未招募）
1 期
PSMA-PET/CT for prostate cancerEUCTR2017-003461-96-BEGhent University Hospital72
进行中（未招募）
1 期
18F-PSMA PET in primary prostate cancer.75 patients with the suspicion on PCa (elevated PSA and/or abnormal digital rectal exam) will receive a PSMA-PET following mpMRI. 25 patients with PIRADS 1-2 (probably benign disease), 25 patients with PIRADS 3 (equivocal disease) and 25 patients with PIRADS 4-5 (highly suspicious for malignancy) will be included in this explorative study.MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-001387-28-NLRadboud University Medical Center75
已完成
2 期
18F-PSMA-1007 PET to detect primary prostate cancer: a comparative study with mpMRI and correlation to histopathologyProstate cancerNL-OMON49534Radboud Universitair Medisch Centrum75
进行中（未招募）
1 期
[18F]PSMA-11 PET/CT for prostate cancer – phase 3 clinical trialprostate cancerEUCTR2018-003168-29-BEGhent University Hospital96
进行中（未招募）
1 期
Comparison of three methosd to identify prostate cancer relapse in patient who precviously have been through curative intended threapyEUCTR2014-005073-37-DKDepartment of Nuclear Medicine, Aalborg University Hospital